Literature DB >> 15042291

[Prognosis of Wilm's tumor in the course of the SIOP trials and studies].

N Graf1, O Semler, H Reinhard.   

Abstract

Wilms' tumor is the most common malignant renal tumor in children. Dramatic improvements in survival have occurred as the result of advances in anesthetic and surgical management, irradiation, and chemotherapy. Today treatments are based on several multicenter trials and studies conducted by the SIOP in Europe and NWTS in the USA. The main objectives of these trials and studies are to treat patients according to well-defined risk groups in order to achieve the highest cure rates, to decrease the frequency and intensity of acute and late toxicity, and to minimize the cost of therapy. The SIOP trials and studies largely focus on the issue of preoperative therapy whereas patients treated according to NWTS are primarily operated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042291     DOI: 10.1007/s00120-004-0551-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  15 in total

Review 1.  Pre- or post-operative treatment for Wilms tumor? Who, what, when, where, how, why--and which.

Authors:  Giulio J D'Angio
Journal:  Med Pediatr Oncol       Date:  2003-12

2.  Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.

Authors:  J de Kraker; N Graf; H van Tinteren; F Pein; B Sandstedt; J Godzinski; M F Tournade
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

3.  The effect of preoperative therapy on the histologic features of Wilms' tumor. An analysis of cases from the Third National Wilms' Tumor Study.

Authors:  C W Zuppan; J B Beckwith; D A Weeks; D W Luckey; K C Pringle
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

4.  Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee.

Authors:  J Godzinski; M F Tournade; J deKraker; J Lemerle; P A Voute; A Weirich; R Ludwig; M Rapala; G Skotnicka; F Gauthier; C G Moorman-Voestermans; D Buerger; A VanVeen; K Sawicz-Birkowska
Journal:  Eur J Pediatr Surg       Date:  1998-04       Impact factor: 2.191

5.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Authors:  M F Tournade; C Com-Nougué; J de Kraker; R Ludwig; A Rey; J M Burgers; B Sandstedt; J Godzinski; M Carli; R Potter; J M Zucker
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

6.  Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee.

Authors:  J de Kraker; J Lemerle; P A Voûte; J M Zucker; M F Tournade; M Carli
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

7.  Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.

Authors:  J Lemerle; P A Voute; M F Tournade; C Rodary; J F Delemarre; D Sarrazin; J M Burgers; B Sandstedt; H Mildenberger; M Carli
Journal:  J Clin Oncol       Date:  1983-10       Impact factor: 44.544

Review 8.  Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: a review.

Authors:  B Jereb; J M Burgers; M F Tournade; J Lemerle; P Bey; J DeLemarre; J L Habrand; P A Voûte
Journal:  Med Pediatr Oncol       Date:  1994

9.  Surgical complications after nephrectomy for Wilms' tumor.

Authors:  M L Ritchey; P P Kelalis; N Breslow; R Etzioni; I Evans; G M Haase; G J D'Angio
Journal:  Surg Gynecol Obstet       Date:  1992-12

Review 10.  The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.

Authors:  D M Green; P R Thomas; S Shochat
Journal:  Hematol Oncol Clin North Am       Date:  1995-12       Impact factor: 3.722

View more
  5 in total

1.  [Childhood kidney tumors -- the relevance of imaging].

Authors:  J-P Schenk; P Günther; C Schrader; S Ley; R Furtwängler; I Leuschner; M Edelhäuser; N Graf; J Tröger
Journal:  Radiologe       Date:  2005-12       Impact factor: 0.635

2.  [Multicystic renal tumor in a patient with WAGR syndrome].

Authors:  K-P Braun; M May; T Erler; B Hoschke
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

3.  [Risk factors for intra- and postoperative complications in Wilms' tumor surgery].

Authors:  V Zugor; D Krot; G E Schott
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

4.  KIT, PDGFRalpha and EGFR analysis in nephroblastoma.

Authors:  Sylvia C Wetli; Ivo Leuschner; Dieter Harms; Alex Rufle; Anja Foerster; Michel Bihl; Norbert Graf; Roikos Furtwaengler; Michael Paulussen; Jakob Briner; Charalampos Aslanidis; Gerd Schmitz; Luigi Tornillo; Michael J Mihatsch; Inti Zlobec; Elisabeth Bruder
Journal:  Virchows Arch       Date:  2008-05-14       Impact factor: 4.064

5.  Childhood renal tumor: a report from a Chinese Children's Cancer Group.

Authors:  Jiaoyang Cai; Ci Pan; Qin Lu; Jie Yan; Xiuli Ju; Futian Ma; Yiping Zhu; Qiuling Liu; Lirong Sun; Lian Jiang; Lizhi Cao; Fu Li; Zhigang Liu; Lijing Qiao; Dongsheng Huang; Xin Tian; Jingyan Tang
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.